1. Home
  2. MAA vs BBIO Comparison

MAA vs BBIO Comparison

Compare MAA & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mid-America Apartment Communities Inc.

MAA

Mid-America Apartment Communities Inc.

HOLD

Current Price

$122.96

Market Cap

15.8B

Sector

Real Estate

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$69.75

Market Cap

15.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MAA
BBIO
Founded
1977
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.8B
15.3B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MAA
BBIO
Price
$122.96
$69.75
Analyst Decision
Buy
Strong Buy
Analyst Count
18
25
Target Price
$149.33
$83.96
AVG Volume (30 Days)
738.1K
2.2M
Earning Date
04-29-2026
04-28-2026
Dividend Yield
5.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$502,076,000.00
Revenue This Year
$2.85
$88.16
Revenue Next Year
$3.13
$74.13
P/E Ratio
$35.71
N/A
Revenue Growth
N/A
126.26
52 Week Low
$121.22
$28.33
52 Week High
$169.42
$84.94

Technical Indicators

Market Signals
Indicator
MAA
BBIO
Relative Strength Index (RSI) 29.62 49.92
Support Level N/A $61.95
Resistance Level $136.72 $78.83
Average True Range (ATR) 2.32 2.84
MACD -0.82 0.40
Stochastic Oscillator 12.89 51.18

Price Performance

Historical Comparison
MAA
BBIO

About MAA Mid-America Apartment Communities Inc.

Mid-America Apartment Communities Inc is a multifamily-focused, self-administered and self-managed real estate investment trust. The company owns, operates, acquires and selectively develops apartment communities located in the Southeast, Southwest and Mid-Atlantic regions of the U.S. Its business objectives are to generate a sustainable, stable and increasing cash flow that will fund its dividends and distributions through all parts of the real estate investment cycle. It operates in two segments, Same Store and Non-Same Store and Other. The majority of the revenue is derived from Same Store segment.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: